Skip to main content

Home/ Vitamin D/ Group items tagged 25ohd Aloia

Rss Feed Group items tagged

Matti Narkia

African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox -- Aloia 88 (2): 54... - 0 views

  •  
    African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox.
    Aloia JF.
    Am J Clin Nutr. 2008 Aug;88(2):545S-550S. Review.
    PMID: 18689399
Matti Narkia

Statins and Vitamin D - 0 views

  •  
    Statins and vitamin D.
    Aloia JF, Li-Ng M, Pollack S.
    Am J Cardiol. 2007 Oct 15;100(8):1329. Epub 2007 Jul 5. No abstract available.
    PMID: 17920383

    A total of 208 women were randomized to receive vitamin D3 (n=104) or placebo (n=104). 51 women were on statins. At baseline, the subjects on statins had a significantly higher 25-OHD level than the subjects who were not on statins (51.2 ± 20.1 nmol/L versus 43.2 ± 18.0 nmol/L respectively, p=0.008). This was also true when averaging 25-OHD levels across the 3-year study period and looking at active and placebo patients separately. 185 subjects had follow-up 25-OHD levels drawn every 6 months during the study. Higher levels were seen in the statin use subgroup whether they were on placebo or active vitamin D (Figure 1Figure 1). There was no interaction seen between vitamin D use and statin use, i.e. the impacts are additive (p=0.5502). This significant difference is comparable to the increase in 25-OHD levels seen in Pérez-Castrillón's study (41 ± 19 versus 47 ± 19 nmol/L, p=0.003) [1]. Although Pérez-Castrillón et al found a statistically significant relation between total cholesterol and 25-OHD (r=0.277, p=0.002), we did not find a significant relation between total cholesterol and 25-OHD in our study population.
Matti Narkia

Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration -- Aloia e... - 0 views

  •  
    Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration.
    Aloia JF, Patel M, Dimaano R, Li-Ng M, Talwar SA, Mikhail M, Pollack S, Yeh JK.
    Am J Clin Nutr. 2008 Jun;87(6):1952-8.
    PMID: 18541590

    The mean daily dose was 86 microg (3440 IU). The use of computer simulations to obtain the most participants within the range of 75-220 nmol/L predicted an optimal daily dose of 115 microg/d (4600 IU). No hypercalcemia or hypercalciuria was observed. CONCLUSIONS: Determination of the intake required to attain serum 25(OH)D concentrations >75 nmol/L must consider the wide variability in the dose-response curve and basal 25(OH)D concentrations. Projection of the dose-response curves observed in this convenience sample onto the population of the third National Health and Nutrition Examination Survey suggests a dose of 95 microg/d (3800 IU) for those above a 25(OH)D threshold of 55 nmol/L and a dose of 125 microg/d (5000 IU) for those below that threshold.
Matti Narkia

A randomized controlled trial of vitamin D3 supplementation for the prevention of sympt... - 0 views

  •  
    A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections.
    Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N.
    Epidemiol Infect. 2009 Mar 19:1-9. [Epub ahead of print]
    PMID: 19296870
Matti Narkia

Dose response to vitamin D supplementation among postmenopausal African American women.... - 0 views

  •  
    Dose response to vitamin D supplementation among postmenopausal African American women.
    Talwar SA, Aloia JF, Pollack S, Yeh JK.
    Am J Clin Nutr. 2007 Dec;86(6):1657-62.
    PMID: 18065583
1 - 5 of 5
Showing 20 items per page